CELLULAR BIOMEDICINE GROUP I's ticker is CBMG and the CUSIP is 15117P102. A total of 41 filers reported holding CELLULAR BIOMEDICINE GROUP I in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $15,082,000 | +74.3% | 953,346 | +78.9% | 0.14% | +3.7% |
| Q4 2019 | $8,653,000 | +4.4% | 532,825 | -4.5% | 0.14% | -7.5% |
| Q3 2019 | $8,288,000 | -5.8% | 557,752 | +4.8% | 0.15% | -15.0% |
| Q2 2019 | $8,799,000 | +30.9% | 532,318 | +37.0% | 0.17% | -2.3% |
| Q1 2019 | $6,721,000 | – | 388,520 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|